-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/stem-cell-children_surveillance.pdf
October 29, 2012 - Stem-Cell Transplantation in the Pediatric
Population
Original release date:
February 01, 2012
Surveillance … Summary Decision:
This CER’s priority for updating is Low
AHRQ Comparative Effectiveness Review
Surveillance … It was therefore due for a surveillance assessment in August, 2012. … Hence, for this surveillance assessment we included only studies with
direct comparisons of treatments … Experts: Still valid
Safety surveillance alerts: No
Conclusion: Up to date
7
Table 1.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/antipsychotics-children-surveillance-150120.pdf
October 01, 2014 - , 2012
Surveillance Report: October, 2014
Summary of Key Findings from Surveillance Reports:
• … Methods
Prior Surveillance
A surveillance report for the original CER was released in November, 2012 … Results
Prior Surveillance
Prior surveillance of the topic included 19 studies and consultation with … -150120
antipsychotics-children-surveillance-150120.2
antipsychotics-children-surveillance-150120.3 … antipsychotics-children-surveillance-150120.4
antipsychotics-children-surveillance-150120.5
antipsychotics-children-surveillance
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/phenylketonuria_surveillance.pdf
January 15, 2013 - PKU Surveillance Assessment_CER 56_Low
CER #56:
Adjuvant Treatment for Phenylketonuria (PKU) … Original release date:
February 2012
Surveillance Report:
January 2013
Key Findings:
• All … Questionnaire Matrix
Surveillance and Identification of Triggers for Updating Systematic Reviews … PKU Surveillance Assessment_CER 56_Low
PKU Surveillance Assessment_CER 56_Low.2
PKU Surveillance Assessment_CER … 56_Low.3
PKU Surveillance Assessment_CER 56_Low.4
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/urinary-incontinence-treatment_surveillance.pdf
October 29, 2012 - Adult
Women: Diagnosis and Comparative Effectiveness
Original release date:
April, 2012
Surveillance … This CER was originally released in April, 2012 and thus
was due for a surveillance assessment in October … Safety surveillance alerts: None
Conclusion: 5/11 conclusions are possibly out of date
17 … _36_Low
Urinary Incontinence Surveillance Assessment_CER_36_Low.2
Urinary Incontinence Surveillance … Assessment_CER_36_Low.3
Urinary Incontinence Surveillance Assessment_CER_36_Low.4
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_surveillance.pdf
June 01, 2012 - Management Strategies
for Renal Artery Stenosis: 2007 Update
Original release date:
2007
Surveillance … It was due for a surveillance assessment immediately. … FDA surveillance alerts: No alert was identified. … FDA surveillance alerts: No alert was identified. … FDA surveillance alerts: No alert was identified.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_surveillance.pdf
May 01, 2013 - Coronary Artery Bypass Grafting
for Coronary Artery Disease
Original release date:
October 2007
Surveillance … When the Surveillance program began in Summer 2011 this CER
was not part of the first wave of reports … for surveillance and was added to our list a few months
ago. … CAD-PCI-bypass-surveillance-130625
CAD-PCI-bypass-surveillance-130625.2
CAD-PCI-bypass-surveillance … -130625.3
CAD-PCI-bypass-surveillance-130625.4
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_surveillance.pdf
May 16, 2013 - Radiofrequency Catheter Ablation for Atrial Fibrillation
Original release date
July 6, 2009
Surveillance … Report (1st Assessment/cycle 1)
November, 2011
Surveillance Report (2nd Assessment/cycle 2)
December … It was therefore due for a surveillance assessment in January,
2010. … The first surveillance assessment report
of this CER was submitted to AHRQ in November, 2011. … -130516
atrial-fibrillation-surveillance-130516.2
atrial-fibrillation-surveillance-130516.3
atrial-fibrillation-surveillance
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_surveillance.pdf
July 01, 2012 - To Reduce Risk of
Primary Breast Cancer in Women
Original release date:
September 14, 2009
Surveillance … Report 1st Assessment: November, 2011
Surveillance Report 2nd Assessment: July, 2012
Key Findings … is Medium (This is
unchanged from the last assessment)
AHRQ Comparative Effectiveness Review
Surveillance … The Surveillance
Program commenced in late summer 2010, and the first assessment of CER #17 was submitted … Cancer Surveillance
November 2011:
Conclusion is still valid and
this portion of the CER does
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_surveillance.pdf
July 01, 2012 - To Reduce Risk of
Primary Breast Cancer in Women
Original release date:
September 14, 2009
Surveillance … Report 1st Assessment: November, 2011
Surveillance Report 2nd Assessment: July, 2012
Key Findings … is Medium (This is
unchanged from the last assessment)
AHRQ Comparative Effectiveness Review
Surveillance … The Surveillance
Program commenced in late summer 2010, and the first assessment of CER #17 was submitted … Cancer Surveillance
November 2011:
Conclusion is still valid and
this portion of the CER does
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
August 01, 2012 - rhGH)
in the Treatment of Patients with Cystic Fibrosis
Original release date:
October 2010
Surveillance … Report 1st Assessment: November, 2011
Surveillance Report 2nd Assessment: August 2012
Key Findings … is Low (This is
unchanged from the last assessment)
AHRQ Comparative Effectiveness Review
Surveillance … Treatment of Patients with Cystic Fibrosis was released in October
2010.1 It was therefore due for a surveillance … The Surveillance
Program commenced in late summer 2010, and the first assessment of CER #23 was submitted
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_surveillance.pdf
October 01, 2012 - Disease Stages 1–3: Screening, Monitoring, and
Treatment
Original release date:
January 2012
Surveillance … Decision
This CER’s priority for updating is Low
AHRQ Comparative Effectiveness Review
Surveillance … Program
AHRQ Comparative Effectiveness Review
Surveillance Program
ii
Authors:
Alicia … 3:
Screening, Monitoring, and Treatment was released in January 2012.1 It was therefore due for a
surveillance … Questionnaire Matrix
Surveillance and Identification of Triggers for Updating Systematic Reviews
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
August 01, 2012 - rhGH)
in the Treatment of Patients with Cystic Fibrosis
Original release date:
October 2010
Surveillance … Report 1st Assessment: November, 2011
Surveillance Report 2nd Assessment: August 2012
Key Findings … is Low (This is
unchanged from the last assessment)
AHRQ Comparative Effectiveness Review
Surveillance … Treatment of Patients with Cystic Fibrosis was released in October
2010.1 It was therefore due for a surveillance … The Surveillance
Program commenced in late summer 2010, and the first assessment of CER #23 was submitted
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_surveillance.pdf
October 01, 2012 - Disease Stages 1–3: Screening, Monitoring, and
Treatment
Original release date:
January 2012
Surveillance … Decision
This CER’s priority for updating is Low
AHRQ Comparative Effectiveness Review
Surveillance … Program
AHRQ Comparative Effectiveness Review
Surveillance Program
ii
Authors:
Alicia … 3:
Screening, Monitoring, and Treatment was released in January 2012.1 It was therefore due for a
surveillance … Questionnaire Matrix
Surveillance and Identification of Triggers for Updating Systematic Reviews
-
www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/mrsa-2/021-ss-mrsa-surveillance-fg.docx
April 01, 2025 - Slide 9
MRSA Surveillance Strategies
SAY:
There are generally two approaches to MRSA surveillance … Slide 10
Passive MRSA Surveillance
SAY:
Passive surveillance gathers data from clinically indicated … than active surveillance. … Slide 11
Active MRSA Surveillance
SAY:
For the purposes of defining active MRSA surveillance, this … Slide 14
Preoperative MRSA Surveillance
SAY:
Within surgical patients, MRSA surveillance could be
-
psnet.ahrq.gov/issue/nursing-surveillance-concept-analysis
May 26, 2021 - Review
Nursing surveillance: a concept analysis
Citation Text:
Halverson … Nursing surveillance: a concept analysis. Nurs Forum. 2022;57(3):454-460. doi:10.1111/nuf.12702. … This review builds on the earlier nursing surveillance concept to reflect technological advancements … Nursing surveillance: a concept analysis. … May 11, 2014
The role of nursing surveillance in keeping patients safe.
-
www.ahrq.gov/hai/tools/mrsa-prevention/surgery/mrsa-surveillance.html
April 01, 2025 - MRSA Prevention Toolkit: Targeting SSI
MRSA Surveillance
Previous Page Next Page
Table … Presentations Presentation: MRSA Surveillance After reviewing the content of this presentation, viewers … will be able to— Describe active and passive approaches for MRSA surveillance Understand the pros and … cons of different MRSA surveillance approaches Outline how to use MRSA surveillance data to inform … Surveillance (DOCX, 344 KB) This one-page document reviews the importance of MRSA surveillance in the
-
www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/mrsa/041-pros-cons-mrsa-surveillance-one-pager.docx
October 01, 2024 - MRSA surveillance provides this type of insight. … MRSA surveillance can be either active or passive. … Utilize the MRSA surveillance data to inform and initiate comprehensive infection prevention strategies … | ICU & Non-ICU MRSA Surveillance Strategies | 2
AHRQ Safety Program for MRSA Prevention | ICU & Non-ICU … MRSA Surveillance Strategies | 1
1.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-e-surveillance-report-1.xlsx
January 01, 2021 - Table E-1. RCT QA
Table E-1. RCT quality assessment
Author,
Year Randomization adequate? Allocation concealment adequate? Groups similar at baseline? Outcome assessors masked? Care provider masked? Patient masked? Intention-to-treat (ITT) analysis Acceptable levels of overall attrition and between-group differences…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-f1-surveillance-report-1.xlsx
November 22, 2021 - Title
Appendix F - Data Abstraction of Efficacy Outcomes
NPP_Pain
Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 Drug 2 Measure Name Measure Scale Assessment Time (wk) Time Category Grp 1 Baseline N Grp 1 Baseline Mean Pain Score Grp1 Baseline Variance Type Grp1 Baseli…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-f2-surveillance-report-1.xlsx
November 22, 2021 - Title
Appendix F2 - Data Abstraction of Harms Outcomes
TCA_PCT
WAE WAE SAE SAE Cardiac Rhythm Abnormalities Cardiac Rhythm Abnormalities Cardiac Rhythm Abnormalities Cardiac Rhythm Abnormalities Cognitive Effects Cognitive Effects Cognitive Effects Cognitive Effects Dry Mouth Dry Mout…